The reason I am posting ELTP-Elite Pharmaceuticals now is exactly what you described... You have had it and seen it range from .04 to .24 in the past 2 years, and now they are finally at the exponential sales growth stage with a full portfolio of products for the USA drug market and the stock is only .106. So a lot of us believe that the next 3 drugs that are imminent to be launched, will turn ELTP into a PROFITABLE drug company that has DEA Controlled Substance Manufacturing approval.
There are only a few drugs that are allowed to manufacture and sell controlled substances in the USA and imported controlled substance drugs are not allowed. Therefore the value of the company is most enhanced by the fact that 3 of the 4 drugs currently on the market are controlled substances.
Here are the current products again, and the pipeline...